These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Management of thymomas. Wright CD Crit Rev Oncol Hematol; 2008 Feb; 65(2):109-20. PubMed ID: 17570676 [TBL] [Abstract][Full Text] [Related]
43. Atypical thymoma (World Health Organization Type B3) with neuroendocrine differentiation combined with hyperparathyroidism. Park HS; Lee SW; Yun SU; Bae BJ; Choi HJ; Kim SY; Choi HJ; Kim WS; Kim HJ; Lee KY J Thorac Oncol; 2010 Sep; 5(9):1490-1. PubMed ID: 20736809 [No Abstract] [Full Text] [Related]
44. The Foundation for Thymic Cancer Research: scope and contributions. Neibauer A Hematol Oncol Clin North Am; 2008 Jun; 22(3):563-73. PubMed ID: 18514133 [TBL] [Abstract][Full Text] [Related]
45. Thymomas and thymic carcinomas: prognostic factors and multimodal management. Moser B; Scharitzer M; Hacker S; Ankersmit J; Matilla JR; Lang G; Aigner C; Taghavi S; Klepetko W Thorac Cardiovasc Surg; 2014 Mar; 62(2):153-60. PubMed ID: 23225512 [TBL] [Abstract][Full Text] [Related]
46. Gene expression profiles of thymic neuroendocrine tumors (carcinoids) with ectopic ACTH syndrome reveal novel molecular mechanism. Bi YF; Liu RX; Ye L; Fang H; Li XY; Wang WQ; Zhang J; Wang KK; Jiang L; Su TW; Chen ZY; Ning G Endocr Relat Cancer; 2009 Dec; 16(4):1273-82. PubMed ID: 19625467 [TBL] [Abstract][Full Text] [Related]
47. Malignant thymoma in an eight-month-old boy. Deshpande GN; Fisher JE; Jewett TC; Freeman AI J Surg Oncol; 1981; 18(1):61-6. PubMed ID: 7289620 [No Abstract] [Full Text] [Related]
48. Hodgkin's disease of the thymus. Krc I; Serý Z; Pavelková L; Duda M Acta Univ Palacki Olomuc Fac Med; 1983; 104():255-8. PubMed ID: 6222607 [No Abstract] [Full Text] [Related]
50. [Thymomas]. Sánchez Heras AB; Pastor Borgoñón M; López Rodríguez A; Montalar Salcedo J An Med Interna; 1989 Dec; 6(12):651-5. PubMed ID: 2491478 [TBL] [Abstract][Full Text] [Related]
51. Thymic neoplasms: an update on the use of chemotherapy and new targeted therapies. A literature review. Berardi R; De Lisa M; Pagliaretta S; Onofri A; Morgese F; Savini A; Ballatore Z; Caramanti M; Santoni M; Mazzanti P; Cascinu S Cancer Treat Rev; 2014 May; 40(4):495-506. PubMed ID: 24355362 [TBL] [Abstract][Full Text] [Related]
52. Thymic Carcinoma Management Patterns among International Thymic Malignancy Interest Group (ITMIG) Physicians with Consensus from the Thymic Carcinoma Working Group. Shepherd A; Riely G; Detterbeck F; Simone CB; Ahmad U; Huang J; Korst R; Rajan A; Rimner A J Thorac Oncol; 2017 Apr; 12(4):745-751. PubMed ID: 27876674 [TBL] [Abstract][Full Text] [Related]
53. Primary neuroendocrine carcinomas of the thymus. Klemm KM; Moran CA Semin Diagn Pathol; 1999 Feb; 16(1):32-41. PubMed ID: 10355652 [TBL] [Abstract][Full Text] [Related]
54. Thymic epithelial neoplasms: a 12-year Canadian regional cancer program experience. Wheatley-Price P; Jonker H; Jonker D; Shamji F; Gomes MM Clin Lung Cancer; 2014 May; 15(3):231-6. PubMed ID: 24485232 [TBL] [Abstract][Full Text] [Related]
55. Current approaches to the treatment of thymoma. Loehrer PJ Ann Med; 1999 Oct; 31 Suppl 2():73-9. PubMed ID: 10574160 [TBL] [Abstract][Full Text] [Related]
56. Diagnosis and treatment of thyroid, adrenal, and thymic tumors. Kenady DE; Sloan DA; Schwartz RW Curr Opin Oncol; 1992 Feb; 4(1):89-98. PubMed ID: 1591297 [TBL] [Abstract][Full Text] [Related]
57. [Chemotherapy for thymic carcinoma]. Okuma Y Gan To Kagaku Ryoho; 2012 May; 39(5):702-7. PubMed ID: 22584319 [TBL] [Abstract][Full Text] [Related]
58. Thymic carcinoma: a report of 13 cases. Lucchi M; Mussi A; Ambrogi M; Gunfiotti A; Fontanini G; Basolo F; Angeletti CA Eur J Surg Oncol; 2001 Nov; 27(7):636-40. PubMed ID: 11669591 [TBL] [Abstract][Full Text] [Related]
59. Primary neuroendocrine carcinoma of thymus: a rare cause of Cushing's syndrome. Arora R; Gupta R; Sharma A; Dinda AK Indian J Pathol Microbiol; 2010; 53(1):148-51. PubMed ID: 20090249 [TBL] [Abstract][Full Text] [Related]